209 participants
Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2024-10-16
- Start Date:
- 2018-06-25
- Completion:
- 2023-05-14
Conditions
- HIV Infections
Interventions
- DRUG